Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Strategic Projects - Group

McGill University

$123,000.00

Designing new vascular stents using polymeric membrane containing baculoviruses

FY 2009-10

Summary
This project deals with the development of a new vascular stent device to improve blood flow in coronary arteries which have been affected by arteriosclerosis. Coronary artery disease characterized by a progressive narrowing and blocking of blood vessels, is major cause of morbidity and mortality in the Western world and accounts for about a fifth of the deaths in Canada. Angioplasty which is an interventional procedure used for reopening blocked arteries without major surgery is a common and effective procedure to reestablish blood flow in the blocked arteries. In 80% of the cases, a stent or wire mesh is often placed to keep the vessel open following the balloon angioplasty procedure. The major limitation to this effective treatment is the reblockage or restenosis of the stented arteries opened after the initial dilatation procedures. Angioplasty and stenting however, causes damage to the endothelial cells lining the blood vessels. We propose a new type of biomedical stenting device which will use nanoparticles containing baculoviruses which carries genes coated on the polymeric membranes. The specific genes will promote the rapid repaving of the damaged arterial lining with natural endothelial cells. The new stent developed is expected to markedly reduce the proliferation of smooth muscles, and therefore, the occurrence of restenosis. This will improve the long-term durability of the stents and also reduce the need for additional interventions or surgery. The development of the new stent would mark a significant advance in the biomedical technologies available for the treatment of cardivascular diseases. A cost effective stent would bring significant benefits to the Canadian healthcare system.
Program
Strategic Projects - Group
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
336317-2006
Name nom
ShumTim, Dominique
Department département
Surgery
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2006
Award amount
123000
Program id
STPGP
Program nane en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Partie
3
Nb partie
3
Application title
Designing new vascular stents using polymeric membrane containing baculoviruses
Keyword
NA
Application summary
This project deals with the development of a new vascular stent device to improve blood flow in coronary arteries which have been affected by arteriosclerosis. Coronary artery disease characterized by a progressive narrowing and blocking of blood vessels, is major cause of morbidity and mortality in the Western world and accounts for about a fifth of the deaths in Canada. Angioplasty which is an interventional procedure used for reopening blocked arteries without major surgery is a common and effective procedure to reestablish blood flow in the blocked arteries. In 80% of the cases, a stent or wire mesh is often placed to keep the vessel open following the balloon angioplasty procedure. The major limitation to this effective treatment is the reblockage or restenosis of the stented arteries opened after the initial dilatation procedures. Angioplasty and stenting however, causes damage to the endothelial cells lining the blood vessels. We propose a new type of biomedical stenting device which will use nanoparticles containing baculoviruses which carries genes coated on the polymeric membranes. The specific genes will promote the rapid repaving of the damaged arterial lining with natural endothelial cells. The new stent developed is expected to markedly reduce the proliferation of smooth muscles, and therefore, the occurrence of restenosis. This will improve the long-term durability of the stents and also reduce the need for additional interventions or surgery. The development of the new stent would mark a significant advance in the biomedical technologies available for the treatment of cardivascular diseases. A cost effective stent would bring significant benefits to the Canadian healthcare system.
McGill University - $123,000 Grant (2009-10) | Canada Spends